Possible role of the aromatase-independent steroid metabolism pathways in hormone responsive primary breast cancers

Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism

(2013) Toru Hanamura et al.   BREAST CANCER RESEARCH AND TREATMENT

Individual transcriptional activity of estrogen receptors in primary breast cancer and its clinical significance

(2012) Tatsuyuki Gohno et al.   Cancer Medicine

Update on adjuvant hormonal treatment of early breast cancer

(2011) Juan Lao Romera et al.   ADVANCES IN THERAPY

Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer

(2011) Emi Tokuda et al.   BREAST CANCER RESEARCH AND TREATMENT

Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene-3β, 17β-diol

(2011) Naoko Honma et al.   CANCER SCIENCE

Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers

(2011) Atul Purohit et al.   JOURNAL OF ENDOCRINOLOGY

Steroid sulfatase inhibitors: Promising new tools for breast cancer therapy?

(2011) Jürgen Geisler et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Aromatase, aromatase inhibitors, and breast cancer

(2011) Saranya Chumsri et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Steroid sulfatase: A pivotal player in estrogen synthesis and metabolism

(2011) Atul Purohit et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Increased estrogen sulfatase (STS) and 17β-hydroxysteroid dehydrogenase type 1(17β-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients

(2010) Niramol Chanplakorn et al.   BREAST CANCER RESEARCH AND TREATMENT

Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment

(2010) Kiyoshi Takagi et al.   ENDOCRINE-RELATED CANCER

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

(2010) M. Elizabeth H. Hammond et al.   JOURNAL OF CLINICAL ONCOLOGY

Adaptive changes results in activation of alternate signaling pathways and resistance to aromatase inhibitor resistance

(2010) Gauri Sabnis et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Steroid sulfatase and estrogen sulfotransferase in human carcinomas

(2010) Takashi Suzuki et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer

(2009) Rowan Chlebowski et al.   BREAST

Characterization of the oestrogenic activity of non-aromatic steroids: are there male-specific endogenous oestrogen receptor modulators?

(2009) Pan Wang et al.   BRITISH JOURNAL OF PHARMACOLOGY

Estrogen signaling pathway and its imaging in human breast cancer

(2009) Shin-ichi Hayashi et al.   CANCER SCIENCE

In situestrogen production and its regulation in human breast carcinoma: From endocrinology to intracrinology

(2009) Hironobu Sasano et al.   PATHOLOGY INTERNATIONAL

The androgen metabolite 5α-androstane-3β,17β-diol (3βAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance

(2008) Matthew J. Sikora et al.   BREAST CANCER RESEARCH AND TREATMENT

Aromatase in Human Breast Carcinoma as a Key Regulator of Intratumoral Sex Steroid Concentrations

(2008) Takashi SUZUKI et al.   ENDOCRINE JOURNAL

Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction

(2008) M. Matsumoto et al.   ENDOCRINE-RELATED CANCER

Structural basis for the selective inhibition of human 3β-hydroxysteroid dehydrogenase 1 in human breast tumor MCF-7 cells

(2008) James L. Thomas et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY